You have read all your free articles, to continue reading subscribe to read the rest of this content.
Genmab has entered an agreement to grant Gilead Sciences, an exclusive license and an option on a second exclusive license, to use the DuoBody technology platform to create and develop bispecific antibody candidates for a therapeutic program targeting HIV. Under the terms of the agreement, GenmabAlready a subscriber Login You…
Scandinavian Biopharma has entered into an agreement with the United States Army Medical Research Acquisition Activity (USAMRAA) to support the production and development of the vaccine, with the long-term goal of preventing bacterial diarrhoea in war fighters. In April this year, SBH announced tAlready a subscriber Login You have read…
In our upcoming issue of Nordic Life Science, Thomas Lönngren, former head of the EMA, emphasizes five important hurdles to identify for the pharmaceutical sector. Thomas Lönngren’s years from the regulatory side and the last ten years as a consultant have provided him with a proper global ovAlready a subscriber…
Elekta has received the EU Medical Device Regulation (EU MDR) certificate for its linear accelerator (linac) portfolio. The MDR certificate applies to the following products, including their components and accessories: Versa HD, Elekta Synergy and Elekta Infinity. The EU MDR will become effectivAlready a subscriber Login You have read all…
